JERSEY CITY, N.J. , June 6, 2024 /PRNewswire/ -- InsightAce Analytic Pvt.
Ltd. announces the release of a market assessment report on the " Peptide Drug Discovery Market - (By Type Of Product (Synthetic Peptides, Biological And Recombinant Peptides And Macrocycles), Drug Discovery Steps (Target Identification And Validation, Hit Identification, Lead Generation And Lead Optimization), Therapeutic Area (Oncological Disorders, Metabolic Disorders, Cardiovascular Disorders, Infectious Disorders, Urological Disorders, Endocrine Disorders, CNS Disorders), Company Size (Small, Mid-Sized And Large & Very Large Companies)), By Region, Trends, Industry Competition Analysis, Revenue And Forecast To 2031." According to the latest research by InsightAce Analytic, the Peptide Drug Discovery Market is valued at US$ 704.
9 Mn in 2023 , and it is expected to reach US$ 1,633.9 Mn by 2031, with a CAGR of 11.3% during the forecast period of 2024-2031.
Peptide drugs have emerged as a promising class of therapeutic agents, due to their high specificity and low toxicity to target specific biological pathways. The process of peptide drug discovery involves a multifaceted approach, integrating advances in chemistry, biology, and computational methods. Recent breakthroughs in design, synthesis, and structure-property relationship analysis have propelled the development of innovative therapies for various diseases, including cancer, metabolic disorders, and neurological conditions.
This multidisciplinar.
